Aldeyra Therapeutics
IPOMedicines to Treat Immune-Mediated Diseases | Aldeyra Therapeutics, Inc.
Public · Lexington, United States · $15.1M raised
- Headquarters
- Lexington, Massachusetts
- Employees
- 11–50
- Business Model
- B2B
- Website
- aldeyra.com
- Total Funding
- $15.1M
- Last Round
- $5.0M Series AJan 2013
- Rounds
- 3
- Type
- Public
About
Aldeyra Therapeutics is a biotechnology company developing innovative therapies for immune-mediated diseases, including rare retinal conditions.
Summary
Aldeyra Therapeutics is a Biotech company based in Lexington, United States. It has raised $15.1M in total across 3 rounds, most recently a $5.0M Series A round in Jan 2013. Investors include Johnson & Johnson.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
May 2014
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...